September 14, 2021
Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Solid Tumors at ESMO Congress 2021
Media
September 13, 2021
Precirix and IFE sign clinical trial manufacturing agreement
September 11, 2021
Oncopeptides presents phase 3 OCEAN study results at the IMW meeting
September 09, 2021
Study results on FORTIFY are inconclusive
September 09, 2021
Webcast for presentation of OCEAN data presented at IMW
September 09, 2021
Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc.
September 02, 2021
Regulatory update from US Food and Drug Administration
August 27, 2021
Oncopeptides presents new data from OCEAN and PORT study – abstracts online
August 27, 2021
Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress
August 27, 2021
Vicore strengthens its management team
